The NIHR Biomedical Research Centre for Mental Health and King’s College London (BRC-MH) have joined GeneGo’s MetaMiner CNS Partnership Program. The goal is to develop a central nervous system (CNS) pathway-analysis platform, which includes developing a series of disease pathway maps for schizophrenia, Alzheimer’s disease, and Huntington’s disease. The program will also leverage experimental data from the public domain and make it available for analysis.








This site uses Akismet to reduce spam. Learn how your comment data is processed.